1. Home
  2. ARVN vs CBNK Comparison

ARVN vs CBNK Comparison

Compare ARVN & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$9.29

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

CBNK

Capital Bancorp Inc.

HOLD

Current Price

$36.58

Market Cap

560.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
CBNK
Founded
2015
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
516.2M
560.3M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
ARVN
CBNK
Price
$9.29
$36.58
Analyst Decision
Buy
Buy
Analyst Count
19
2
Target Price
$15.05
$35.50
AVG Volume (30 Days)
898.7K
47.3K
Earning Date
05-04-2026
04-27-2026
Dividend Yield
N/A
1.52%
EPS Growth
58.84
60.85
EPS
1.70
1.60
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$16.20
Revenue Next Year
N/A
$8.52
P/E Ratio
$5.51
$22.83
Revenue Growth
N/A
N/A
52 Week Low
$6.97
$26.40
52 Week High
$14.22
$38.83

Technical Indicators

Market Signals
Indicator
ARVN
CBNK
Relative Strength Index (RSI) 58.81 48.16
Support Level $7.90 $34.40
Resistance Level $9.65 $36.71
Average True Range (ATR) 0.36 0.65
MACD 0.04 -0.25
Stochastic Oscillator 73.65 27.44

Price Performance

Historical Comparison
ARVN
CBNK

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About CBNK Capital Bancorp Inc.

Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage. The company generates majority revenue from the Commercial bank sector. Commercial Banking division focuses on providing personalized service to commercial clients throughout the operations supplemented by lending outside primary market as well as engaging in government guaranteed lending on a national basis.

Share on Social Networks: